The two other supporting mechanisms for cancer promotion and drug resistance in B16F10 cells include PRP4-induced inhibition of Ca2+ influx through CaSR desensitization and remodeling of the cell actin cytoskeleton by the downregulation of the AC–cAMP–RhoA signaling pathway (Graphical abstract). The gene discussed is CASR; the disease is cancer.